Tatva Chintan Pharma Chem Limited

NSEI:TATVA 주식 보고서

시가총액: ₹20.0b

Tatva Chintan Pharma Chem 대차 대조표 상태

재무 상태 기준 확인 6/6

Tatva Chintan Pharma Chem has a total shareholder equity of ₹7.4B and total debt of ₹152.3M, which brings its debt-to-equity ratio to 2.1%. Its total assets and total liabilities are ₹8.1B and ₹694.2M respectively. Tatva Chintan Pharma Chem's EBIT is ₹197.1M making its interest coverage ratio -11.6. It has cash and short-term investments of ₹148.7M.

주요 정보

2.1%

부채 비율

₹152.31m

부채

이자 보상 비율-11.6x
현금₹148.73m
주식₹7.38b
총 부채₹694.18m
총 자산₹8.07b

최근 재무 상태 업데이트

업데이트 없음

Recent updates

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Sep 26
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Aug 29
Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Jul 27
Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

May 11
Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

Apr 04
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Jan 26
These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

May 10
Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Jul 28
Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Jun 17
Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

May 03
Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

Dec 06
Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

재무 상태 분석

단기부채: TATVA's short term assets (₹2.5B) exceed its short term liabilities (₹678.2M).

장기 부채: TATVA's short term assets (₹2.5B) exceed its long term liabilities (₹15.9M).


부채 대 자본 내역 및 분석

부채 수준: TATVA's net debt to equity ratio (0.05%) is considered satisfactory.

부채 감소: TATVA's debt to equity ratio has reduced from 85% to 2.1% over the past 5 years.

부채 범위: TATVA's debt is well covered by operating cash flow (259.2%).

이자 보장: TATVA earns more interest than it pays, so coverage of interest payments is not a concern.


대차 대조표


건강한 기업 발견하기